34 results

• Andexxa Stroke Lawsuit Alleges Blood Thinner Reversal Drug Caused Falls, Vision Problems

  October 22, 2026

  Irvin Jackson

  A man's lawsuit blames the recalled blood thinner reversal agent, Andexxa, for life-threatening blood clots resulting in a stroke.

• Lawsuit Alleges Andexxa Administered To Reverse Xarelto Effects Caused Near-Fatal Thrombotic Event

  May 28, 2026

  Irvin Jackson

  A medical malpractice lawsuit claims side effects of the recalled blood thinner reversal agent, Andexxa, caused a man to suffer serious thromboembolic events.

• Pacemaker-Associated Infections Lead to Recurrent Pulmonary Embolisms in 39-Year-Old Man: Study

  March 5, 2026

  Martha Garcia

  A case study of a man with recurrent pulmonary emboli revealed that an infected pacemaker lead was causing the development of blood clots.

• Eliquis, Xarelto Bleeding Risks Renewed Amid Andexxa Recall Tied to Stroke, Heart Attack Concerns

  January 9, 2026

  Irvin Jackson

  Recent recall of Andexxa causes Xarelto and Eliquis users to go without an FDA-approved reversal agent, leaving doctors to rely on a drug known to be less effective and to cause blood clots.

• Andexxa Recall Announced After FDA Says Xarelto, Eliquis Reversal Agent Risks Outweigh Benefits

  December 22, 2025

  Irvin Jackson

  AstraZeneca is removing its blood thinner reversal agent Andexxa from the market after the FDA determined the drug's blood clot risks outweigh its benefits.

• Macular Degeneration Eye Hemorrhage Risks Linked to Blood Thinners: Study

  September 18, 2025

  Martha Garcia

  The use of blood thinners and antiplatelet medications appear to increase the risk of eye bleeds in patients with macular degeneration, according to a new study.

• Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis

  November 21, 2024

  Irvin Jackson

  Safety concerns linked to Andexxa, the reversal agent for newer blood thinners like Xarelto and Eliquis, will be discussed at an FDA advisory panel meeting today, after postmarketing studies indicated the drug doubled the risks of blood clots and death.

• Study Links Serious Bleeding Risks to Diltiazem Combination Therapy With Anticoagulants for Atrial Fibrillation

  April 19, 2024

  Martha Garcia

  Cardizem and Viazem could increase the risk of bleeding in atrial fibrillation patients being treated with Xarelto and Eliquis, a new study warns.

• Eliquis Lowers Stroke Risk, But Side Effects Linked to Higher Risk of Major Bleeding: Study

  January 17, 2024

  Katherine McDaniel

  A new study reveals Eliquis decreases the risk of stroke in patients with subclinical atrial fibrillation, but at the cost of an increased risk of major bleeding events.

• Blood Thinner Extended Use Study Finds Little Difference in Warfarin, Xarelto, Eliquis Bleeding Rates

  March 18, 2022

  Irvin Jackson

  A new study finds little difference in major bleeding events between the newer blood thinners Xarelto and Eliquis and the older blood thinner warfarin they were supposed to replace.